The U.S. Food and Drug Administration

FDA approves leukemia drug of Agios Pharmaceuticals

by News Hour Correspondent - Jul 22, 2018

Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation. The company plans to launch...
The U.S. Food and Drug Administration approved Novo Nordisk’s diabetes drug Ozempic

by News Hour Correspondent - Dec 6, 2017

Ozempic, known generically as semaglutide, will compete with others in a class known as glucagon-like peptide-1 (GLP-1) analogs, which imitate an intestinal hormone that stimulates the production of insulin. The U.S. Food and Drug Administration on...
FDA approved a new indication for Victoza® to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes

by News Hour Correspondent - Aug 31, 2017

News Hour: The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza® (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events in adults with type 2 diabetes and established CV...
FDA expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc

by News Hour Correspondent - Aug 18, 2017

News Hour: The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing treatment of patients with recurrent ovarian cancer who have...
Pfizer Inc’s process for manufacturing contaminated drugs at a plant Kansas was “out of control”, warns FDA

by News Hour Correspondent - Mar 1, 2017

News Hour: The U.S. Food and Drug Administration said Pfizer Inc’s process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas was “out of control” and put patients at risk, according to a warning...
The US FDA grants priority review to Novartis drug Zykadia

by News Hour Correspondent - Feb 23, 2017

News Hour: The U.S. Food and Drug Administration (FDA) has granted priority review to Novartis drug Zykadia as a first-line treatment for some lung cancer patients, the Swiss drugmaker said on Thursday. The priority review covers...

The U.S. Food and Drug Administration

FDA approves leukemia drug of Agios Pharmaceuticals

The U.S. Food and Drug Administration approved Novo Nordisk’s diabetes drug Ozempic

FDA approved a new indication for Victoza® to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes

FDA expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc

Pfizer Inc’s process for manufacturing contaminated drugs at a plant Kansas was “out of control”, warns FDA

The US FDA grants priority review to Novartis drug Zykadia

Facebook

Twitter

The U.S. Food and Drug Administration

FDA approves leukemia drug of Agios Pharmaceuticals

The U.S. Food and Drug Administration approved Novo Nordisk’s diabetes drug Ozempic

FDA approved a new indication for Victoza® to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes

FDA expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc﻿

Pfizer Inc’s process for manufacturing contaminated drugs at a plant Kansas was “out of control”, warns FDA

The US FDA grants priority review to Novartis drug Zykadia

Facebook

Twitter

FDA expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc